"The Company believes it currently has enough drug product and substance to complete its contemplated clinical activity and will be transitioning the aforementioned services to one, or several, of its current service providers."
It's getting so easy to discredit these dumb paid bashers. They just don't get it.
Oh what happened to the no money left over claim when CytoDyn rips up AmarX. LMAO, well, Samsung deal nixes that. What great business negotiation skills our new CEO possesses.
Come on pigeons, Give me MORE! $CYDY$ 2024 Getting more bullish by the day.
Our competition Pfizer being sued again by Texas AG,huge new suits from Amazon, Target Stores, and many others. Massive put trades yesterday and today, Thinking I will short again PFE and go long CYDY. Just my opinion!
Bullish
Market Data 
Markets 
AI
